- Report
- July 2026
- 189 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- August 2026
- 225 Pages
Global
From €5249EUR$5,850USD£4,483GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- January 2026
- 191 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- June 2026
- 198 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- January 2026
- 197 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- January 2026
- 191 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- April 2026
Global
From €4396EUR$4,900USD£3,755GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- August 2026
- 372 Pages
Global
From €5249EUR$5,850USD£4,483GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- January 2026
- 180 Pages
Global
From €4037EUR$4,500USD£3,449GBP
- Report
- January 2026
- 185 Pages
Global
From €4037EUR$4,500USD£3,449GBP
- Report
- December 2025
- 200 Pages
Global
From €7133EUR$7,950USD£6,093GBP
- Report
- April 2026
- 180 Pages
Global
From €4262EUR$4,750USD£3,640GBP

Thrombin is a hematological drug used to treat bleeding disorders. It is a naturally occurring enzyme in the body that helps to form blood clots. Thrombin is used to treat a variety of conditions, including hemophilia, deep vein thrombosis, and pulmonary embolism. It is also used to help control bleeding during surgery. Thrombin is available in both injectable and topical forms. The injectable form is used to treat more serious conditions, while the topical form is used to treat minor cuts and scrapes.
The thrombin market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Novo Nordisk, Bayer, and Sanofi. Other companies in the market include CSL Behring, Grifols, and Kedrion Biopharma. Show Less Read more